ReviewJournal of neuroinflammation2026
HSV-1 reactivation as an emergent property of neuronal stress: implications for traumatic brain injury.
Review in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Herpes simplex virus type 1 (HSV-1) establishes lifelong latency in neurons, with reactivation driven by multiple molecular, cellular, and systemic stressors. While several individual mechanisms of reactivation have been well characterized, there are potentially other unresolved vulnerabilities that drive HSV-1 reactivation. Traumatic brain injury (TBI) has emerged as a potential trigger of HSV-1 reactivation and represents a complex and clinically relevant perturbation that disrupts neuronal homeostasis, immune surveillance, and inflammatory signaling, processes that are also central to HSV-1 latency and reactivation. However, the mechanisms linking TBI to HSV-1 reactivation remain poorly understood.In this review, we examine whether known mechanisms of TBI-induced cellular stress overlap with pathways implicated in HSV-1 latency and reactivation. We synthesize shared mechanisms, including stress signaling, neuroinflammation, and immune dysregulation during TBI that may create conditions permissive for HSV-1 reactivation in the injured brain. This integrated perspective reframes TBI as a context in which established drivers of HSV-1 reactivation converge and may increase reactivation susceptibility.We propose that HSV-1 reactivation is an emergent property of dysregulated neural systems and that TBI may engage many of these processes. In this framework, viral reactivation is inseparable from the broader neuronal and systemic context in which it occurs. This perspective highlights the importance of integrating neural state, injury, and immune dynamics into models of HSV-1 latency and reactivation. Advancing this multidimensional view will be critical for developing therapeutic strategies that not only suppress viral reactivation but also address neuroinflammation following brain injury.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.